伯恩斯坦将三只欧洲制药股列为最佳买入标的,板块重估在即
- 提供者Investing.com-
Investing.com -- 欧洲制药板块作为必备防御性板块重新受到关注,而伯恩斯坦已明确给出了其选择。在最近的一份研报中,该...
最新 | 最高 | 最低 | |||||
|---|---|---|---|---|---|---|---|
| 260.40 | 262.00 | 256.80 | -1.60 | -0.61% | 40.56K | ||
| 80.45 | 80.85 | 79.25 | -0.10 | -0.12% | 33.87K | ||
| 103.10 | 104.20 | 102.30 | -0.90 | -0.87% | 439.37K | ||
| 26.58 | 26.86 | 25.90 | +0.48 | +1.84% | 457.58K | ||
| 76.20 | 76.90 | 75.75 | -0.40 | -0.52% | 102.15K | ||
| 252.00 | 254.80 | 245.20 | +0.70 | +0.28% | 292.98K | ||
| 59.02 | 59.32 | 58.20 | -0.40 | -0.67% | 1.64M | ||
| 61.75 | 61.75 | 60.90 | +0.40 | +0.65% | 425.37K | ||
| 16.04 | 16.50 | 15.93 | -0.33 | -2.02% | 635.18K | ||
| 68.25 | 68.55 | 67.45 | +0.05 | +0.07% | 123.47K | ||
| 126.60 | 130.80 | 124.60 | -2.90 | -2.24% | 151.35K | ||
| 9,570.0 | 9,710.0 | 9,420.0 | -100.0 | -1.03% | 520 | ||
| 50.95 | 52.55 | 50.55 | -2.05 | -3.87% | 53.6K | ||
| 63.50 | 64.10 | 63.20 | -0.80 | -1.24% | 39.14K | ||
| 207.80 | 220.20 | 207.80 | -10.80 | -4.94% | 60.86K | ||
| 22.14 | 22.26 | 21.82 | -0.14 | -0.63% | 400.9K | ||
| 158.40 | 159.10 | 156.60 | +1.60 | +1.02% | 53.76K | ||
| 607.40 | 613.80 | 600.00 | +5.60 | +0.93% | 137.13K | ||
| 8.26 | 8.28 | 8.10 | +0.03 | +0.36% | 495.68K | ||
| 49.00 | 49.87 | 48.16 | -0.27 | -0.55% | 280.27K |
Investing.com -- 欧洲制药板块作为必备防御性板块重新受到关注,而伯恩斯坦已明确给出了其选择。在最近的一份研报中,该...
智通财经APP获悉,申万宏源发布研报称,美以军事行动致使伊朗关闭霍尔木兹海峡,从霍尔木兹海峡通行量骤降表现来看,已实现船东担忧情...
Investing.com -- DEME集团的荷兰竞争对手Boskalis周四宣布,2025财年EBITDA增长3%,达到创纪录...
无排定利润报告